Preclinical
NanoStat™
ACTRN12618000208202
Treatment of high cholesterol
NanoCelle® mRNA
COVID-19 vaccine
NanoCelle® Butyrate
Adjuvant to enhance oxaliplatin efficacy for treatment of mesothelioma / large bowel cancer
NanoCelle® Medicated gauze
Antibiotics
Phase 1
NanaBidial™
ACTRN12617001491358
NanoCelle™ Cannabidiol Pharmocokinetic Study
MultiBiotic™
ACTRN12618000927224
Treatment of chemotherapy-induced intestinal mucositis
NanoCBD™
Treatment of stress and mild anxiety
Phase 2
NRGBiotic™
ACTRN12614000544673
Adjunctive therapy for treatment of depression
NanaBis™
ACTRN12617001480370
Treatment of advanced cancer pain
Phase 3
NanaBis™
ACTRN12621001302842
Treatment of bone pain from metastatic cancers
Location: AUS, UK, US
Real World evidence observational studies*
NanaBis™
ACTRN12619000513112
Treatment of cancer and non-cancer related pain
Location: AUS
NanaBis™
IN DEVELOPMENT
Treatment of cancer and non-cancer related pain
Location: US
* Real-world observational data complement clinical trial findings, accelerating Medlab's clinical pathway and regulation strategy.
^ NanaBidal™ successfully completed a phase 1 pharmacokenetic trial but will no longer continue into further clinical trials.
Pre-clinical completed work and proven fields of use
- NanoCelle® Lidocaine Treatment of mild to moderate pain
- NanoCelle® Loratadine Treatment of allergy symptoms
- NanUlin™ Treatment of type 2 diabetes
- NanoCelle® Dermatan sulfate Anticoagulant
- NanoCelle® Smart clothing Anticoagulant